copiamycin

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Kimura, Ken-Ichi: 1 article (01/2010)
2.	Takahashi, Hidetoshi: 1 article (01/2010)
3.	Tsuchiya, Eiko: 1 article (01/2010)
4.	Ueno, Masaru: 1 article (01/2010)
5.	Yukawa, Masashi: 1 article (01/2010)

1.	Ulcer 02/01/1991 - "Inhibitory effects of copiamycin A, a macrocyclic lactone antibiotic, on gastric H+,K(+)-ATPase, acid secretion and ulcer formation."
2.	Neoplasms (Cancer) 01/01/2010 - "We performed screening on culture broth of various microbes, and identified five compounds, borrelidin, mycophenolic acid, UCS15A, copiamycin analog, and fredericamycin A, that were known to possess anti-tumor activity. "
3.	Infections 06/01/1971 - "Local administration of copiamycin to mice inoculated intraperitoneally with protozoa reduced the per cent of infection as measured by decreased abscess formation. "
4.	Abscess 06/01/1971 - "Local administration of copiamycin to mice inoculated intraperitoneally with protozoa reduced the per cent of infection as measured by decreased abscess formation. "

1.	H(+)-K(+)-Exchanging ATPase (Hydrogen, Potassium ATPase)
2.	Mycophenolic Acid (Cellcept)
3.	Lactones
4.	Anti-Bacterial Agents (Antibiotics)
5.	Acids
6.	UCS15A
7.	fredericamycin A
8.	borrelidin